Tag: Khosla-Ventures

2 articles

Market Moves

Sabi raises $50 million for a brain-sensing baseball cap

Khosla Ventures has led a $50 million seed round in Sabi, a California startup building a baseball cap meant to turn imagined words and trained mental commands into text and instructions for AI assistants. Accel, Initialized Capital, former OpenAI chief product officer Kevin Weil, DST Global, Collaborative Fund and Ascend also invested, Sabi announced on 9 October 2026. Forbes put the valuation at $600 million, citing a person familiar with the deal. The cap is designed to read brain signals through hair with sensors built around a custom EEG chip, and to decode them with a model Sabi says was trained on more than 100,000 hours of labelled recordings. In April, Sabi said its first product would be a beanie available by the end of 2026. The cap will now debut as an early prototype at CES in January, and Forbes reported that it will not be available until 2027. Sabi has named no price and published no peer-reviewed results, and its only accuracy figure, up to 77 per cent, comes from a wired laboratory prototype.

Oct 11

Industry News

Science Corporation names Darius Shahida President as PRIMA retinal implant enters commercial rollout

Science Corporation, Max Hodak's Alameda-headquartered neural engineering and brain-computer interface company, announced on 17 September 2026 that Chief Strategy Officer Darius Shahida has been appointed President in a dual role. Shahida joined full-time in January 2026 as CSO after eight years at Butterfly Network and after first participating in Science's Series B as an investor. He is the second senior Butterfly Network alumnus hired by Science this year; Nevada Sanchez, a Butterfly Network co-founder, joined as EVP Engineering on 29 July 2026. The Shahida appointment lands two months into the European commercial rollout of PRIMA, Science's photovoltaic subretinal implant for geographic atrophy in age-related macular degeneration, which received CE mark from DEKRA in July 2026 (30 European countries; commercial launch also covers the UK) and simultaneous FDA Breakthrough Device and Humanitarian Use Device designations. Science closed a $230 million Series C on 5 March 2026 from Khosla Ventures, Lightspeed, Y Combinator, IQT, Quiet Capital and others, bringing total capital raised to roughly $490 million since founding in 2021. Hodak remains CEO. The company operates from Alameda with offices in Paris and Research Triangle Park.

Sep 19